DAY TWO

8:00 am Coffee & Networking

8:55 am Chair’s Opening Remarks

Navigating the Landscape: Building Spatial Biology Capabilities & Advancing Drug Discovery

9:00 am Reserved for Flagship Biosciences

9:30 am Panel Discussion: Navigating Strategic Choices: Building Internal Capabilities vs. Partnering with External Experts in Spatial Biology

Synopsis

  • Outlining the factors that influence whether an organization should build internal spatial biology capabilities or work with external partners
  • Delving into case studies of organizations that chose to scale through internal development and those that successfully worked with CROs to expand their capabilities
  • Analysing how hybrid models provide flexibility, reduce risks, and ensure a balance of internal control and external expertise

10:15 am From Bench to Breakthroughs: Leveraging Spatial Transcriptomics Platforms in Early Discovery & Beyond

  • Oscar Echeagaray Next Generation Sequencing Research Scientist, Bristol Myers Squibb

Synopsis

  • Discussing how spatial transcriptomics can be utilized in early drug discovery to identify novel targets and understand disease mechanisms at a cellular level
  • Exploring the benefits of integrating spatial transcriptomics with other orthogonal technologies
  • Addressing the current challenges in spatial transcriptomics, such as data complexity, cost, and technical limitations, and discussing potential solutions and future directions

10:45 am Technology Slam

Synopsis

As you enjoy your morning refreshments on Day Two, you will have the opportunity to be face-to-face with the field’s most innovative and exciting modelling technologies and supporting platform providers. This dedicated technology slam session will enable you to identify your next go-to technology provider and advance your drug development workflow effectively

11:15 am Morning Break & Networking

Enhancing Target Profiling & Understanding Immune Dynamics to Navigate Cell-Cell Interactions

11:45 am Innovation in Preclinical & Translational Safety: Unveiling Spatial Target Expression Profiling with CosMx

Synopsis

  • Leveraging cutting-edge CosMx technology to generate comprehensive tissue expression profiles in human tissues, enabling precise spatial mapping of molecular targets within complex tissues
  • Achieving unparalleled spatial resolution by using CosMx to profile target expression at the single-cell level within tissue microarrays, unlocking insights into cell-specific responses and behaviors in several tissues in one slide
  • Utilizing spatial transcriptomics data to assess safety profiles and identify potential toxicological effects, driving informed decision-making in drug development and preclinical safety assessments

12:15 pm Roundtable: Mapping Immune Reactions in the Tumor Microenvironment

Synopsis

  • Diving into the spatial patterns of T-cell exhaustion within the TME and how these insights can inform novel immunotherapy strategies
  • Investigating how spatial biology is used to identify regions of immunosuppression within tumors and the implications for treatment response
  • Discussing how spatial technologies can capture the movement and interactions of immune cells over time to better understand immune dynamics in the TME

12:45 pm Spatial Transcriptomics Reveal Interplay Between CAFs & Tumorphagocytic TAMs that Governs Immunosuppression

Synopsis

  • Exploring the technical aspects and innovations that enable high-resolution mapping of cellular interactions
  • Detailing how high-resolution spatial mapping reveals insights into cell-cell interactions within tissues
  • Reviewing examples where these techniques have been used to study immune cell interactions, tumor-stroma dynamics, and neuronal networks

1:15 pm Lunch & Networking

Unifying Spatial Technologies & Standardizing Data Processing

2:15 pm Multi-Platform Spatial Precision & Validation for Clinical Applications

  • Daniel Chawla Senior Biologist, Computational & Immuno-Oncology, Pfizer

Synopsis

  • Evaluating inter- and intra-run precision of Xenium and Visium platforms across diverse clinical FFPE samples, ensuring reliable results for clinical studies
  • Developing methods for integrating spatial technologies into a unified coordinate system, facilitating accurate comparisons and improving validation processes
  • Quantifying spatial concordance across multiple platforms, demonstrating the suitability of 10X spatial profiling for clinical assays and advancing confidence in data-driven decisions

2:45 pm Panel Discussion: Standardizing Data Processing Across Spatial Biology Platforms

  • Lauri Diehl Executive Director, Research Pathology, Gilead
  • Sripad Ram Digital Pathology & Image Analysis Group Lead, Pfizer

Synopsis

  • Summarising the challenges of inconsistencies in data processing due to varied computational tools and resources
  • Outlining current efforts and proposals for developing universal or standardized methods
  • Navigating case studies of successful standardization initiatives and their impact

3:15 pm Closing Remarks

3:20 pm End of Conference